# Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

> **NCT03188419** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 161 (actual)

## Conditions studied

- Primary T-cell Immunodeficiency Disorders
- Common Variable Immunodeficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03188419
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-14
- **Primary completion:** 2019-12-29
- **Final completion:** 2020-02-20
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188419, "Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03188419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*